Kafa, a 55-year-old patient from Rafah in the southern Gaza Strip, was repeatedly denied access to treatment abroad by Israeli authorities.
Kafa, who was diagnosed with chronic lymphocytic leukemia (CLL) in August 2018, underwent chemotherapy at the European Hospital in Khan Younis, in the Gaza Strip. After initially responding well to chemotherapy, in January 2020 she was referred to the Istishari Hospital in Ramallah, in the West Bank, to receive a medicine called ibrutinib, a monoclonal antibody used in the treatment of CLL.
Doctors had detected that she had a relapse and that the disease was not responding to her previous treatment regimen.
“I submitted ten permit applications to Israeli authorities to cross Erez to reach treatment, but they only approved one of my applications,” said Kafa.
Many #cancer treatments unavailable in #Gaza, yet frequent denials or delays to granting of permits by Israel frequently stop #women from leaving for treatment elsewhere. Cancer #patients whose permits initially delayed or denied almost 50% more likely to die in subsequent years https://t.co/VaHCQMzojq
— Medical Aid for Palestinians (@MedicalAidPal) October 15, 2020
Kafa first applied for a hospital appointment in November 2019. She was requested for security interrogation, but she reports that she waited all day at Beit Hanoun/Erez checkpoint and had to return to Gaza after no one met with her.
In December 2019 and January 2020, she applied for another four appointments but all were either denied or delayed.
Finally, in February 2020 after a delay of approximately three months and after appealing the decisions of Israeli authorities through the Palestinian Centre for Human Rights and Al Mezan Centre for Human Rights, Kafa was approved a permit to travel for treatment. She first had to undergo security interrogation at Beit Hanoun/Erez checkpoint.
When Illness Is a ‘Death Sentence’: The Victimization of Gaza Women https://t.co/7YxjKcqgGU via @PalestineChron pic.twitter.com/HiN6rKmPXp
— Ramzy Baroud (@RamzyBaroud) May 24, 2019
She commented,
“I was requested for security interrogation about ten days before my appointment. During the interrogation, the Israeli officer noticed my poor health and told me that he would allow me to cross to receive care. I was so happy that I had been approved. After that, I reached Istishari Hospital for my medical treatment, but it was the only time I’ve been able to access the hospital.”
Between February and October 2020, Kafa did not apply to travel for treatment, due to the severity of the COVID-19 outbreak in Israel and the West Bank. She remained in the Gaza Strip, with her ability to apply for a permit to exit complicated by the Palestinian Authority’s end to the coordination of permit applications during this period.
In 2017 more than 700 Palestinian patients from #Gaza denied axes to the outside world, for treatment abroad. #SaveGaza #GazaSiege #GazaToUN #IsraeliApartheid #BDS pic.twitter.com/zWLHSEQD0S
—
In October 2020, however, after another relapse in her illness, Kafa applied again to reach treatment outside the Gaza Strip – this time through WHO’s temporary coordination mechanism for patient and companion permit applications.
Since October 2020, Kafa has made four unsuccessful permit applications to exit the Gaza Strip for treatment. She was also requested to undergo security interrogation again.
Kafa works as a cleaner in one of the Ministry of Health hospitals in the Gaza Strip. She has a family of six children and her illness has made it difficult to continue her work and her care for her children.
She commented, “I am suffering from severe pain in my stomach and my left leg gets more swollen every day. I need treatment that we don’t have here [in Gaza]. Is it not my right to get that treatment? I don’t want my health to deteriorate again.”
(WAFA, PC, Social Media)
The post WHO Report: Israel Denies Gaza Leukemia Patient Access to Treatment Abroad appeared first on Palestine Chronicle.